Full View

Alternative stabilities of a proline‐rich antibacterial peptide in vitro and in vivo

PB Noto, G Abbadessa, M Cassone, GD Mateo… - Protein …, 2008 - Wiley Online Library
The proline‐rich designer antibacterial peptide dimer A3‐APO is currently under preclinical
development for the treatment of systemic infections caused by antibiotic‐resistant Gram …
被引用次数：77 相关文章

Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo.

PB Noto, G Abbadessa, M Cassone… - Protein Science: a …, 2008 - europepmc.org
The proline-rich designer antibacterial peptide dimer A3-APO is currently under preclinical
development for the treatment of systemic infections caused by antibiotic-resistant Gram …
[HTML] nih.gov

[HTML][HTML] Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo

PB Noto, G Abbadessa, M Cassone… - Protein Science: A …, 2008 - ncbi.nlm.nih.gov
The proline-rich designer antibacterial peptide dimer A3-APO is currently under preclinical
development for the treatment of systemic infections caused by antibiotic-resistant Gram …

Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo

PB Noto, G Abbadessa, M Cassone… - Protein science: a …, 2008 - pubmed.ncbi.nlm.nih.gov
The proline-rich designer antibacterial peptide dimer A3-APO is currently under preclinical
development for the treatment of systemic infections caused by antibiotic-resistant Gram …
[PDF] academia.edu

[PDF][PDF] Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo

PB NOTO, G ABBADESSA, M CASSONE… - Protein …, 2008 - academia.edu
The proline-rich designer antibacterial peptide dimer A3-APO is currently under preclinical
development for the treatment of systemic infections caused by antibiotic-resistant Gram …

Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo.

PB Noto, G Abbadessa, M Cassone… - Protein Science: a …, 2008 - europepmc.org
The proline-rich designer antibacterial peptide dimer A3-APO is currently under preclinical
development for the treatment of systemic infections caused by antibiotic-resistant Gram …
[PDF] academia.edu

[PDF][PDF] Alternative stabilities of a proline-rich antibacterial peptide in vitro and in vivo

PB NOTO, G ABBADESSA, M CASSONE… - Protein …, 2008 - academia.edu
The proline-rich designer antibacterial peptide dimer A3-APO is currently under preclinical
development for the treatment of systemic infections caused by antibiotic-resistant Gram …